Fingerprint
Dive into the research topics of 'A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
Todd A. Fehniger, Geoffrey L. Uy, Kathryn Trinkaus, Alissa D. Nelson, Jeffery Demland, Camille N. Abboud, Amanda F. Cashen, Keith E. Stockerl-Goldstein, Peter Westervelt, John F. DiPersio, Ravi Vij
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences
- Siteman Cancer Center
- Human Research Protection Office (HRPO)
- Section of Bone Marrow Transplant & Leukemia
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Section of Stem Cell Biology
- Division of Oncology
- Center of Regenerative Medicine
- DBBS - Immunology
- DBBS - Cancer Biology
Research output: Contribution to journal › Article › peer-review
99
Scopus
citations